YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
RNA-binding proteins (RBPs) are critical regulators of transcription and translation that are often dysregulated in cancer. Although RBPs are increasingly recognized as being important for normal hematopoiesis and for hematologic malignancies as oncogenes or tumor suppressors, RBPs that are essential for the maintenance and survival of leukemia remain elusive. Here we show that YBX1 is specifically required for maintaining myeloid leukemia cell survival in an N6-methyladenosine (m6A)-dependent manner. We found that expression of YBX1 is significantly upregulated in myeloid leukemia cells, and deletion of YBX1 dramatically induces apoptosis and promotes differentiation coupled with reduced proliferation and impaired leukemic capacity of primary human and mouse acute myeloid leukemia cells in vitro and in vivo. Loss of YBX1 has no obvious effect on normal hematopoiesis. Mechanistically, YBX1 interacts with insulin-like growth factor 2 messenger RNA (mRNA)-binding proteins (IGF2BPs) and stabilizes m6A-tagged RNA. Moreover, YBX1 deficiency dysregulates the expression of apoptosis-related genes and promotes mRNA decay of MYC and BCL2 in an m6A-dependent manner, which contributes to the defective survival that results from deletion of YBX1. Thus, our findings have uncovered a selective and critical role of YBX1 in maintaining myeloid leukemia survival, which might provide a rationale for the therapeutic targeting of YBX1 in myeloid leukemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“YBX1 is an oncogenic pro-survival factor in leukemia”
From Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia (2024) · cites this paper as [53]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012) · Nature · doi:10.1038/nature11112 · Cited by 4,884
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Jia, G., Fu, Y., Zhao, X., Dai, Q., Zheng, G., Yang, Y., Yi, C., Lindahl, T., Pan, T., Yang, Y.-G., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.687 · Cited by 4,106
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
Zheng, G., Dahl, J. A., Niu, Y., Fedorcsak, P., Huang, C.-M., Li, C. J., Vågbø, C. B., Shi, Y., Wang, W.-L., Song, S.-H., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.015 · Cited by 3,550
A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., Jia, G., Yu, M., Lu, Z., Deng, X., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1432 · Cited by 3,433
Döhner, H., Weisdorf, D. J., & Bloomfield, C. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1406184 · Cited by 3,306
Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0045-z · Cited by 2,997
Self-citationFrequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029
A brave new world of RNA-binding proteins
Hentze, M. W., Castello, A., Schwarzl, T., & Preiss, T. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.130 · Cited by 1,821
Identification of Methylated Nucleosides in Messenger RNA from Novikoff Hepatoma Cells
Desrosiers, R., Friderici, K., & Rottman, F. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.3971 · Cited by 1,757
Lagadinou, E. D., Sach, A., Callahan, K., Rossi, R. M., Neering, S. J., Minhajuddin, M., Ashton, J. M., Pei, S., Grose, V., O’Dwyer, K. M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.013 · Cited by 1,399
RNA-binding proteins: modular design for efficient function
Lunde, B. M., Moore, C., & Varani, G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2178 · Cited by 1,321
Vu, L. P., Pickering, B. F., Cheng, Y., Zaccara, S., Nguyen, D., Minuesa, G., Chou, T., Chow, A., Saletore, Y., MacKay, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4416 · Cited by 1,237
Self-citationPromoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
Barbieri, I., Tzelepis, K., Pandolfini, L., Shi, J., Millán-Zambrano, G., Robson, S. C., Aspris, D., Migliori, V., Bannister, A. J., Han, N., et al. (2017) · Nature · doi:10.1038/nature24678 · Cited by 1,086
The dynamic epitranscriptome: N6-methyladenosine and gene expression control
Meyer, K. D., & Jaffrey, S. R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3785 · Cited by 1,060
Context-dependent control of alternative splicing by RNA-binding proteins
Fu, X.-D., & Ares, M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3778 · Cited by 1,044
m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways
Li, H.-B., Tong, J., Zhu, S., Batista, P. J., Duffy, E. E., Zhao, J., Bailis, W., Cao, G., Kroehling, L., Chen, Y., et al. (2017) · Nature · doi:10.1038/nature23450 · Cited by 977
Weng, H., Huang, H., Wu, H., Qin, X., Zhao, B. S., Dong, L., Shi, H., Skibbe, J., Shen, C., Hu, C., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.016 · Cited by 968
Self-citation5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs
Chen, X., Li, A., Sun, B.-F., Yang, Y., Han, Y.-N., Yuan, X., Chen, R.-X., Wei, W.-S., Liu, Y., Gao, C.-C., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0361-y · Cited by 801
Self-citationCampos, L., Rouault, J., Sabido, O., Oriol, P., Roubi, N., Vasselon, C., Archimbaud, E., Magaud, J., & Guyotat, D. (1993) · Blood · doi:10.1182/blood.v81.11.3091.3091 · Cited by 784
Pollyea, D. A., Stevens, B. M., Jones, C. L., Winters, A., Pei, S., Minhajuddin, M., D’Alessandro, A., Culp-Hill, R., Riemondy, K. A., Gillen, A. E., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0233-1 · Cited by 778
RNA-Binding Proteins in Cancer: Old Players and New Actors
Pereira, B., Billaud, M., & Almeida, R. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.05.003 · Cited by 773
Thiol-linked alkylation of RNA to assess expression dynamics
Herzog, V. A., Reichholf, B., Neumann, T., Rescheneder, P., Bhat, P., Burkard, T. R., Wlotzka, W., von Haeseler, A., Zuber, J., & Ameres, S. L. (2017) · Nature Methods · doi:10.1038/nmeth.4435 · Cited by 622
Thiol-linked alkylation for the metabolic sequencing of RNA
Herzog, V. A., Reichholf, B., Neumann, T., Rescheneder, P., Bhat, P., Burkard, T. R., Wlotzka, W., von Haeseler, A., Zuber, J., & Ameres, S. L. (2017) · doi:10.1101/177642 · Cited by 622
m6A modulates haematopoietic stem and progenitor cell specification
Zhang, C., Chen, Y., Sun, B., Wang, L., Yang, Y., Ma, D., Lv, J., Heng, J., Ding, Y., Xue, Y., et al. (2017) · Nature · doi:10.1038/nature23883 · Cited by 582
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Graubert, T. A., Shen, D., Ding, L., Okeyo-Owuor, T., Lunn, C. L., Shao, J., Krysiak, K., Harris, C. C., Koboldt, D. C., Larson, D. E., et al. (2012) · Nature Genetics · doi:10.1038/ng.1031 · Cited by 580
Paris, J., Morgan, M., Campos, J., Spencer, G. J., Shmakova, A., Ivanova, I., Mapperley, C., Lawson, H., Wotherspoon, D. A., Sepulveda, C., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.03.021 · Cited by 502
Molecular Mechanisms Driving mRNA Degradation by m6A Modification
Lee, Y., Choe, J., Park, O. H., & Kim, Y. K. (2020) · Trends in Genetics · doi:10.1016/j.tig.2019.12.007 · Cited by 450
Evdokimova, V., Tognon, C., Ng, T., Ruzanov, P., Melnyk, N., Fink, D., Sorokin, A., Ovchinnikov, L. P., Davicioni, E., Triche, T. J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.017 · Cited by 444
Yang, Y., Wang, L., Han, X., Yang, W.-L., Zhang, M., Ma, H.-L., Sun, B.-F., Li, A., Xia, J., Chen, J., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.033 · Cited by 432
Self-citationYB ‐1 protein: functions and regulation
Lyabin, D. N., Eliseeva, I. A., & Ovchinnikov, L. P. (2014) · WIREs RNA · doi:10.1002/wrna.1200 · Cited by 381
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia
Kharas, M. G., Lengner, C. J., Al-Shahrour, F., Bullinger, L., Ball, B., Zaidi, S., Morgan, K., Tam, W., Paktinat, M., Okabe, R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2187 · Cited by 379
Shen, C., Sheng, Y., Zhu, A. C., Robinson, S., Jiang, X., Dong, L., Chen, H., Su, R., Yin, Z., Li, W., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.04.009 · Cited by 373
Self-citationTargeting an RNA-Binding Protein Network in Acute Myeloid Leukemia
Wang, E., Lu, S. X., Pastore, A., Chen, X., Imig, J., Chun-Wei Lee, S., Hockemeyer, K., Ghebrechristos, Y. E., Yoshimi, A., Inoue, D., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.010 · Cited by 338
Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs
Weidensdorfer, D., Stöhr, N., Baude, A., Lederer, M., Köhn, M., Schierhorn, A., Buchmeier, S., Wahle, E., & Hüttelmaier, S. (2009) · RNA · doi:10.1261/rna.1175909 · Cited by 318
Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis
El-Naggar, A. M., Veinotte, C. J., Cheng, H., Grunewald, T. G. P., Negri, G. L., Somasekharan, S. P., Corkery, D. P., Tirode, F., Mathers, J., Khan, D., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.003 · Cited by 283
The major mRNA-associated protein YB-1 is a potent 5' cap-dependent mRNA stabilizer
Evdokimova, V. (2001) · The EMBO Journal · doi:10.1093/emboj/20.19.5491 · Cited by 279
YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1
Somasekharan, S. P., El-Naggar, A., Leprivier, G., Cheng, H., Hajee, S., Grunewald, T. G. P., Zhang, F., Ng, T., Delattre, O., Evdokimova, V., et al. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201411047 · Cited by 278
Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion
Li, Z., Qian, P., Shao, W., Shi, H., He, X. C., Gogol, M., Yu, Z., Wang, Y., Qi, M., Zhu, Y., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0072-0 · Cited by 257
WTAP is a novel oncogenic protein in acute myeloid leukemia
Bansal, H., Yihua, Q., Iyer, S. P., Ganapathy, S., Proia, D., Penalva, L. O., Uren, P. J., Suresh, U., Carew, J. S., Karnad, A. B., et al. (2014) · Leukemia · doi:10.1038/leu.2014.16 · Cited by 243
Wang, J., Li, Y., Wang, P., Han, G., Zhang, T., Chang, J., Yin, R., Shan, Y., Wen, J., Xie, X., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.04.001 · Cited by 243
Self-citationLee, H., Bao, S., Qian, Y., Geula, S., Leslie, J., Zhang, C., Hanna, J. H., & Ding, L. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0318-1 · Cited by 235
Janz, M., Harbeck, N., Dettmar, P., Berger, U., Schmidt, A., Jürchott, K., Schmitt, M., & Royer, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.1610 · Cited by 182
Gao, Y., Vasic, R., Song, Y., Teng, R., Liu, C., Gbyli, R., Biancon, G., Nelakanti, R., Lobben, K., Kudo, E., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.003 · Cited by 180
Self-citationShibahara, K., Sugio, K., Osaki, T., Uchiumi, T., Maehara, Y., Kohno, K., Yasumoto, K., Sugimachi, K., & Kuwano, M. (2001) · PubMed · Cited by 173
m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment
Cheng, Y., Luo, H., Izzo, F., Pickering, B. F., Nguyen, D., Myers, R., Schurer, A., Gourkanti, S., Brüning, J. C., Vu, L. P., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.032 · Cited by 169
Self-citationSplicing factor YBX1 mediates persistence of JAK2-mutated neoplasms
Jayavelu, A. K., Schnoeder, T. M., Perner, F., Herzog, C., Meiler, A., Krishnamoorthy, G., Huber, N., Mohr, J., Edelmann-Stephan, B., Austin, R. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2968-3 · Cited by 163
The RNA-binding protein YBX1 regulates epidermal progenitors at a posttranscriptional level
Kwon, E., Todorova, K., Wang, J., Horos, R., Lee, K. K., Neel, V. A., Negri, G. L., Sorensen, P. H., Lee, S. W., Hentze, M. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04092-0 · Cited by 99
Self-citationRNA-binding proteins in hematopoiesis and hematological malignancy
Hodson, D. J., Screen, M., & Turner, M. (2019) · Blood · doi:10.1182/blood-2018-10-839985 · Cited by 78
Kolk, A., Jubitz, N., Mengele, K., Mantwill, K., Bissinger, O., Schmitt, M., Kremer, M., & Holm, P. S. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.491 · Cited by 47
Wu, Y., Wang, K., Li, Z., Liu, Y., Izumi, H., Yamada, S., Uramoto, H., Nakayama, Y., Ito, K., & Kohno, K. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1208-4 · Cited by 19
m=6A修飾は造血発生時の内因性二本鎖RNAの形成と有害な自然免疫応答を阻止する【JST・京大機械翻訳】
Yimeng, G., Vasic, R., Yuanbin, S., Rhea, T., Chengyang, L., Gbyli, R., Biancon, G., Nelakanti, R. V., Lobben, K., Kudo, E., et al. (2020) · Immunity · Cited by 17
High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
Yokoyama, H., Harigae, H., Takahashi, S., Kameoka, J., Miyamura, K., Ishizawa, K., Kaku, M., & Sasaki, T. (2003) · International Journal of Hematology · doi:10.1007/bf02983797 · Cited by 11
Cited by
Yang, Y., Li, S., Wang, Y., Zhao, Y., & Li, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01168-8 · Cited by 294
Self-citationRNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer
Li, W., Deng, X., & Chen, J. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.025 · Cited by 175
Self-citationLiu, W.-W., Zheng, S.-Q., Li, T., Fei, Y.-F., Wang, C., Zhang, S., Wang, F., Jiang, G.-M., & Wang, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01777-5 · Cited by 166
Self-citationThe role of RNA methylation in tumor immunity and its potential in immunotherapy
Li, Y., Jin, H., Li, Q., Shi, L., Mao, Y., & Zhao, L. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02041-8 · Cited by 184
Self-citationMethylation across the central dogma in health and diseases: new therapeutic strategies
Liu, R., Zhao, E., Yu, H., Yuan, C., Abbas, M. N., & Cui, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01528-y · Cited by 168
Metadata
- Authors
- Feng, M., Xie, X., Han, G., Zhang, T., Li, Y., Li, Y., Yin, R., Wang, Q., Zhang, T., Wang, P., Hu, J., Cheng, Y., Gao, Z., Wang, J., Chang, J., Cui, M., Gao, K., Chai, J., Liu, W., Guo, C., Li, S., Liu, L., Zhou, F., Chen, J., & Zhang, H.
- Affiliations
- Wuhan University (CN)
- The State Key Laboratory Breeding Base of Basic Science of Stomatology–Key Laboratory of Oral Biomedicine, Ministry of Education, School and Hospital of Stomatology, and
- University of Massachusetts Chan Medical School (US)
- Wuhan Union Hospital (CN)
- City of Hope (US)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2021-03-24
- Volume
- 138
- Issue
- 1
- Pages
- 71-85
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC8667054
- OpenAlex
- W3137919635
- Cited by
- 213
- References
- 52
- Citations by year
- 2026: 28 · 2025: 55 · 2024: 48 · 2023: 34 · 2022: 37 · 2021: 11
- FWCI
- 10.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Natural Science Foundation of China (81500133, 81722003, 81870124)
- Natural Science Foundation of Hubei Province (81500133, 2018CFA018, 2019CFA073)
- Wuhan University (TFJC2018005)
- National Key Research and Development Program of China (2017YFA0505600)
- Wuhan Science and Technology Project
- National Cancer Institute (R01CA214965, R01CA243386, R01CA236399, R01CA245147, R01CA222590, R01CA211614)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124116, R56DK120282)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- YB-1, myeloid leukemia, leukemia cell survival, N6-methyladenosine, RNA methylation, IGF2BP, RNA-binding proteins, mRNA stability, c-Myc, apoptosis, differentiation, therapeutic target
- MeSH terms
- Adenosine, Animals, Cell Survival, Hematopoiesis, Humans, Mice, Inbred C57BL, RNA, Neoplasm, Leukemia, Myeloid, Acute, Gene Expression Regulation, Leukemic, Proto-Oncogene Proteins c-myc, RNA-Binding Proteins, Apoptosis, Gene Deletion, Proto-Oncogene Proteins c-bcl-2, Mice, Y-Box-Binding Protein 1, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.